Gene Editing
Investment in biotechnology driven by gene editing technologies (e.g., CRISPR), benefiting from breakthroughs and commercialization.24H Performance
0.51%
Beta1.44
Post-market | Last updated at Jun 25, 2026 16:28:31© 2026 Edgen Powered by